Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
J Med Microbiol ; 59(Pt 7): 797-803, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20223895

RESUMEN

In this study the role of the TOP2 gene in fungal drug susceptibility was investigated by disrupting and overexpressing the gene in Candida albicans. MIC determination and a spot assay showed that a top2Delta/Delta null mutant (strain T2bc) was more resistant to the antifungals tested than the wild-type (strain CAI4). Real-time RT-PCR and rhodamine 6G efflux examination showed that TOP2 did not influence the activity of drug efflux pumps. Sterol analysis with GC/high-resolution MS indicated that the intracellular ergosterol composition of the top2Delta/Delta mutant was significantly increased. Subsequently, fluorescence polarization measurements also revealed that Top2-deprived cells displayed a decrease in membrane fluidity, resulting in enhanced passive diffusion of the drugs. Quantitative real-time RT-PCR analysis further confirmed that the ERG11 gene, an essential gene in ergosterol biosynthesis, was upregulated. These results demonstrate a close relationship between the TOP2 gene and drug susceptibility in C. albicans.


Asunto(s)
Antifúngicos/farmacología , Candida albicans/efectos de los fármacos , ADN-Topoisomerasas de Tipo II/genética , Ergosterol/biosíntesis , Proteínas Fúngicas/genética , Regulación Fúngica de la Expresión Génica/fisiología , Candida albicans/genética , Candida albicans/metabolismo , ADN-Topoisomerasas de Tipo II/metabolismo , Farmacorresistencia Fúngica/genética , Ergosterol/genética , Proteínas Fúngicas/metabolismo , Pruebas de Sensibilidad Microbiana , Mutación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA